Funding for this research was provided by:
Länsstyrelsen Östergötland (LIO – 697501)
Received: 5 May 2020
Accepted: 16 September 2020
First Online: 13 October 2020
Ethics approval and consent to participate
: The Regional Ethics Committee of Linköping approved the protocol (Ref. 2014/123-31), and the study was registered at ExternalRef removed NCT02172092 on June 24, 2014, which is before any patient had been recruited (Principal Investigator: Joachim Zdolsek).
: Not applicable.
: RGH holds a grant from Grifols for the study of 20% albumin as infusion fluid. RS and JZ declare that they have no conflict of interest.